Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-06-16 | Since February 2020, Ms. Ross has served as CEO of ChroniSense Medical, Ltd., developer of a wearable medical-grade disease management device, and since January 2020, she has also served as advisor to Picomole, Inc., a medical technology company focused on developing a breath test for lung cancer. Additionally, Ms. Ross serves on the steering committee of MassMedic and as the Executive in Residence for the association's IGNITE accelerator program. From 2017 to 2018, Ms. Ross was President of the Global Medical Group and member of the Executive Management team at Henry Schein, Inc., an international medical and dental product distributor/solutions provider. From 1988 to 2017 she held numerous senior leadership roles at Johnson & Johnson, Inc., including, most recently VP of Commercial Operations for Medical Devices, North America. Ms. Ross holds a Bachelor of Commerce degree from the University of Alberta. |
| 2021-04-20 | Ms. Ross has served as CEO of ChroniSense Medical, Ltd., and advisor to Picomole, Inc., with a Bachelor of Commerce degree. |
| 2022-04-14 | Ms. Ross has served as CEO of ChroniSense Medical, Ltd., developer of a wearable medical-grade disease management device, and advisor to Picomole, Inc., a medical technology company. |
| 2023-04-14 | Ms. Ross serves as CEO and Board Director of ChroniSense Medical, an early-stage medical device company focused on transforming chronic care with Polso CONNECT™, a remote patient monitoring solution. She has served as a mentor for the Canadian Technology Accelerator and MassMEDIC’s IGNITE Accelerator program. From 1988 to 2017 she held numerous senior leadership roles at Johnson & Johnson. |
| 2024-04-16 | Ms. Ross has served as CEO and Board Director of medical device companies and has a Bachelor of Commerce degree from the University of Alberta. |
Data sourced from SEC filings. Last updated: 2026-02-03